These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26040645)

  • 1. Four decades of National Blood Service in Iran: outreach, prospect and challenges.
    Pourfathollah AA; Hosseini Divkolaye NS; Seighali F
    Transfus Med; 2015 Jun; 25(3):138-43. PubMed ID: 26040645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety.
    Omidkhoda A; Razi B; Arabkhazaeli A; Amini Kafi-Abad S
    BMC Infect Dis; 2020 Oct; 20(1):736. PubMed ID: 33028232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H
    Transfus Med; 2009 Aug; 19(4):189-94. PubMed ID: 19708860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience.
    Cheraghali AM; Abolghasemi H
    Haemophilia; 2009 Mar; 15(2):487-93. PubMed ID: 19347989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of blood transfusion system of iran: 2002-2011.
    Cheraghali A
    Iran J Public Health; 2012; 41(8):89-93. PubMed ID: 23113231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013.
    Keshvari M; Sharafi H; Alavian SM; Mehrabadi H; Zolfaghari S
    Transfus Apher Sci; 2015 Aug; 53(1):38-47. PubMed ID: 25892591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predonation screening of candidate donors and prevention of window period donations.
    Lieshout-Krikke RW; Zaaijer HL; van de Laar TJ
    Transfusion; 2015 Feb; 55(2):373-8. PubMed ID: 25130605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
    Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden.
    Davidson T; Ekermo B; Gaines H; Lesko B; Åkerlind B
    Transfusion; 2011 Feb; 51(2):421-9. PubMed ID: 20849409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and trends of hepatitis C virus among blood donors in Antananarivo, from 2003 to 2009.
    Randriamanantany ZA; Rajaonatahina DH; Razafimanantsoa FÉ; Rasamindrakotroka MT; Andriamahenina R; Rasoarilalaomanarivo FB; Hanitriniala SP; Herisoa FR; Rakoto-Alson OA; Rasamindrakotroka A
    Transfus Clin Biol; 2012 Apr; 19(2):52-6. PubMed ID: 22410302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful exclusion of blood-borne viral disease in blood donors.
    Ramezani H; Bozorgi SH; Nooranipour M; Sadri M; Molaverdikhani S; Alavian SM
    Eur J Intern Med; 2011 Dec; 22(6):e71-4. PubMed ID: 22075316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
    Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
    Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in hepatitis B and hepatitis C virus seropositivity among blood donors over 15 years screened in the blood bank of a university hospital.
    Dilsiz G; Yenicesu I; Belen FB; Celik B; Ozturk G
    Transfus Apher Sci; 2012 Aug; 47(1):95-100. PubMed ID: 22595695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
    Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for hepatitis B and C infection among blood donors in five Chinese blood centers.
    Huang Y; Guo N; Yu Q; Lv Y; Ma H; Yun Z; Yao F; Dong X; Zhu X; Wen X; Cao R; Huang M; Bi X; Zhao M; Tiemuer MH; Li J; Zhou Z; He W; Liu J; Wright DJ; Wang J; Ness P; Shan H;
    Transfusion; 2015 Feb; 55(2):388-94. PubMed ID: 25382751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A successful experience of the Iranian blood transfusion organization in improving accessibility and affordability of plasma derived medicine.
    Chegini A; Torab SA; Pourfatollah AA
    Transfus Apher Sci; 2017 Feb; 56(1):12-16. PubMed ID: 28214180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of donor selection on blood safety in Iran.
    Razjou F; Maghsudlu M; Nasizadeh S; Zadsar M
    Transfus Apher Sci; 2012 Aug; 47(1):13-6. PubMed ID: 22521567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive serology for viral hepatitis and donor self-exclusion in Southern Brazil.
    Maccarini Jde L; Nazario CA; Ferreira Jdos S; Ceglio WQ; Serpa RC; Ferreira VL; Lucca Schiavon Ld; Narciso-Schiavon JL
    Rev Soc Bras Med Trop; 2013; 46(4):403-10. PubMed ID: 23982095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papua New Guinea Red Cross Blood Transfusion Service: present status and future considerations.
    Tozer RA
    P N G Med J; 1996 Mar; 39(1):38-42. PubMed ID: 9522849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.